Clinical Responses to Sildenafil in Waldenstrom's Macroglobulinemia
- 1 December 2004
- journal article
- case report
- Published by Elsevier BV in Clinical Lymphoma
- Vol. 5 (3), 205-207
- https://doi.org/10.3816/clm.2004.n.029
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Uniform response criteria in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cellsBlood, 2003
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBritish Journal of Clinical Pharmacology, 2002